IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Talaris Therapeutics Inc

CUSIP: 87410C104 | 125 institutional holders

Quarters

Q3 2024Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Lindbrook Capital, LLC56
0.0% of portfolio›$1.4K
StyleTurnoverLocationFiled
Lindbrook Capital, LLC
56$1.4K0.0%GrowthVery LowCalabasas, United Kingdom2024-11-01